Latimer, N. R., Bell, H., Abrams, K. R., Amonkar, M. M., & Casey, M. (2016). Adjusting for treatment switching in the METRIC study shows further improved overall survival with trametinib compared with chemotherapy. Cancer Med.
Citação norma ChicagoLatimer, Nicholas R., Helen Bell, Keith R. Abrams, Mayur M. Amonkar, and Michelle Casey. "Adjusting for Treatment Switching in the METRIC Study Shows Further Improved Overall Survival With Trametinib Compared With Chemotherapy." Cancer Med 2016.
MLA CitationLatimer, Nicholas R., et al. "Adjusting for Treatment Switching in the METRIC Study Shows Further Improved Overall Survival With Trametinib Compared With Chemotherapy." Cancer Med 2016.
Advarsel: Disse citationer er muligvist ikke 100% nøjagtige.